Harvard University
Determinants of carotid endarterectomy anatomic durability identified
Published in Cardiovascular Business Week, July 5th, 2005
CEA "remains the gold standard for treatment of carotid stenosis," vascular surgeons in the United States explained. "With inevitable comparisons of catheter-based therapy to all aspects of CEA," a "study of a large contemporary series was undertaken to evaluate the determinants of anatomic durability of CEA."
"During the interval (1989 through 1999), 2,127 primary, isolated CEAs with selective patching (50.2%) were performed in 1,853 patients (61.8% male, 36.1% symptomatic)," according to G.M. Lamuraglia and colleagues at Harvard...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Biosensors International Group, Ltd.
Medical device maker reports significant increase in revenue - Edwards Lifesciences
Agreement between PVT and 3F Therapeutics restructured in light of acquisition - Martek Biosciences Corporation
Biosciences corporation announces second quarter financial results - Osiris Therapeutics, Inc.
Adult stem cell therapy company finalizes investment round - OXIS International, Inc.
Company focused on diseases of oxidative stress discusses financials - Aarhus University Hospital
Research in diabetes pathogenesis provides new insights - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
